Re: Paraganglioma in the bladder wall: A case report

The case report by Freires et al.[1], titled “Paraganglioma in the bladder wall: A case report,” presents a rare and intriguing instance of bladder paraganglioma, a type of extra‐adrenal pheochromocytoma. This case highlights the importance of recognizing and appropriately managing these uncommon tumors, which can pose significant diagnostic and therapeutic challenges.

Recent studies have provided further insights into the characteristics and management of bladder paragangliomas. A review of 20 cases at Sun Yat‐sen University Cancer Center highlighted that most patients were asymptomatic, with tumors often detected incidentally[2]. The study also noted significant intraoperative arterial pressure fluctuations, underscoring the need for careful perioperative management.

Another study[3] emphasized the importance of distinguishing bladder paragangliomas from urothelial carcinomas, as the former can present similarly but require different management strategies. The prognosis for nonmetastatic bladder paragangliomas is generally favorable, with surgical excision being highly effective.

1 KEY FINDINGS

1.1 Incidence and presentation

Bladder paragangliomas are exceedingly rare, accounting for less than 0.06% of all bladder tumors and less than 1% of all pheochromocytomas. These tumors often present with symptoms such as headache, tachycardia, hypertension, and hematuria, which are indicative of catecholamine secretion. In this case, the patient exhibited frequent headaches and tachycardia, initially attributed to anxiety.

1.2 Diagnostic approach

The diagnosis of bladder paraganglioma in this patient was incidental, discovered during a prostate ultrasound. Subsequent imaging and cystoscopy confirmed the presence of a nodular lesion in the bladder wall. This aligns with the literature, which emphasized the role of imaging techniques such as ultrasound, computed tomography, and magnetic resonance imaging in identifying these tumors. Biochemical tests, including urinary metanephrines, were also crucial for diagnosis.

1.3 Surgical management

The patient underwent partial cystectomy and ureterectomy, which was consistent with the recommended treatment for bladder paragangliomas. Surgical resection remained the primary treatment modality, with partial cystectomy being the most common approach. Preoperative management often included alpha‐blockade to prevent intraoperative hypertensive crises, although this was unnecessary in the presented case due to normal preoperative blood pressure levels.

2 CONCLUSION

The case report by Freires et al.[1] contributes valuable knowledge to the limited literature on bladder paragangliomas. It underscores the necessity of a thorough diagnostic workup and highlights the effectiveness of surgical management. Given the rarity of these tumors, continued documentation and research are essential to improve understanding and treatment outcomes. This case serves as a reminder for clinicians to consider paragangliomas in the differential diagnosis of bladder masses, particularly in patients presenting with symptoms of catecholamine excess.

References

[1] Freires TS, Pereira JMBSM, Capuzi ERA, Coelho OC, Silva RDB, Maciel LC. Paraganglioma in the bladder wall: a case report. UroPrecision. 2024;2:157–160.

[2] Cai T, Lu J, Lin Z, Luo M, Liang H, Qin Z, et al. Bladder paraganglioma: basic characteristics and new perspectives on perioperative management. World J Urol. 2022;40(11):2807–2816.

[3] Saha A, Saha K, Sarkar N, Geelani IA. Paraganglioma of urinary bladder: an uncommon entity in uropathology. Cureus. 2021;13(8):e17265.

RIGHTS & PERMISSIONS

2024 The Author(s). UroPrecision published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.